Building access to the Regenstrief Institute is restricted at least through May 3, 2020. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief research scientist Noll Campbell, PharmD, M.S., spoke about a common class of drugs and how it affects the brain on an Indianapolis radio show.

Dr. Campbell was a guest on Caregiver Crossing, which airs every Saturday on 93.1 WIBC. Dr. Campbell addressed the topic of anticholinergics and their potential link to Alzheimer’s and dementia. Anticholinergics are a common class of drug that includes some allergy medications, sleeping pills and many more common medicines.

Dr. Campbell recently received a $3.3 million grant from the National Institute on Aging to conduct the first clinical trial designed to determine if stopping these medications results in sustained improvements in cognition.

Listen to his discussion with the Caregiver Crossing hosts and his advice for people who are taking these medications.

Segment 1

 

Segment 2

Click here for more information on Caregiver Crossing.

Related News

Apr 03, 2020 • News
Facilitating communication and collaboration among care teams in times of crisis
Regenstrief, IU Kelley School of Business, and SoPE hosting webinar on collaborative care strategies The COVID-19 pandemic has changed communication and workflow for nearly everyone, including healthcare workers. Regenstrief Institute, the Indiana University Kelley Business of Medicine Program and the Society of Physician Entrepreneurs (SoPE) Indiana Chapter are hosting a webinar to offer strategies and…
Continue Reading >
Apr 02, 2020 • News
International audience attends webinar addressing standard terminology needs for recording COVID-19 test results
Video, slides and resources available online Hundreds of people from around the world attended a virtual meeting focusing on health data standards needed during the COVID-19 pandemic. The webinar, presented by LOINC®, highlighted the team’s efforts to create common terminology to identify laboratory tests for the novel coronavirus, SARS-CoV-2. LOINC, short for Logical Observation Identifiers…
Continue Reading >